| Zacks Company Profile for COSCIENS Biopharma Inc. (CSCIF : OTC) |
|
|
| |
| • Company Description |
| COSCIENS Biopharma Inc. is a holding company, operating through its subsidiaries. Its principal operating subsidiary, Ceapro Inc. is focused on the development and commercialization of natural, plant-based active ingredients derived from oats and other renewable plant resources, using proprietary manufacturing and extraction technologies. The company's primary active ingredient business activities relate to the development and commercialization of natural products for personal care, cosmetic, human and animal health industries using proprietary technology, natural, renewable resources and developing innovative products, technologies and delivery systems. COSCIENS Biopharma Inc. is based in TORONTO, ONTARIO.
Number of Employees: 28 |
|
|
| |
| • Price / Volume Information |
| Yesterday's Closing Price: $4.98 |
Daily Weekly Monthly
 |
| 20 Day Moving Average: 124 shares |
| Shares Outstanding: 1.06 (millions) |
| Market Capitalization: $5.29 (millions) |
| Beta: 1.46 |
| 52 Week High: $9.50 |
| 52 Week Low: $0.79 |
| Short Interest Ratio: |
| |
% Price Change |
% Price Change Relative to S&P 500 |
| 4 Week |
-5.95% |
-5.28% |
| 12 Week |
-22.80% |
-24.43% |
| Year To Date |
-19.43% |
-28.12% |
|
|
|
|
| |
| • Address & Contact Information |
| Street Address |
Phone / Fax |
Email Address |
Web URL |
22 ADELAIDE STREET WEST SUITE 3400
-
TORONTO,A6 M5H 4E3
CAN |
ph: 843-900-3223
fax: 418-948-9191 |
csci@jtcir.com |
http://www.cosciensbio.com |
|
|
| |
| • General Corporate Information |
Officers
Peter H. Puccetti - Interim Chief Executive Officer and Chairman of th
Gerlach, Matthias - Senior Vice President; Managing Director
La Fratta, Giuliano - Chief Financial Officer
Giovinazzo, Anthony J. - Director
Kosciessa, Ulrich - Director
|
|
Peer Information
COSCIENS Biopharma Inc. (CORR.)
COSCIENS Biopharma Inc. (RSPI)
COSCIENS Biopharma Inc. (CGXP)
COSCIENS Biopharma Inc. (BGEN)
COSCIENS Biopharma Inc. (GTBP)
COSCIENS Biopharma Inc. (RGRX)
|
|
Industry / Sector / Ticker Info
Analyst Coverage: No
Industry Group: MED-BIOMED/GENE
Sector: Medical
CUSIP: 22112H200
SIC: 2844
|
|
Fiscal Year
Fiscal Year End: December
Last Reported Quarter: 06/01/26
Next Expected EPS Date: 11/10/26
|
|
Share - Related Items
Shares Outstanding: 1.06
Most Recent Split Date: 7.00 (0.33:1)
Beta: 1.46
Market Capitalization: $5.29 (millions)
|
|
|
|
|
| |
| • EPS Information |
• Dividend Information |
| Analyst Coverage: No |
Dividend Yield: 0.00% |
| Current Fiscal Quarter EPS Consensus Estimate: $ |
Indicated Annual Dividend: $0.00 |
| Current Fiscal Year EPS Consensus Estimate: $ |
Payout Ratio: |
| Number of Estimates in the Fiscal Year Consensus: |
Change In Payout Ratio: |
| Estmated Long-Term EPS Growth Rate: % |
Last Dividend Paid: NA - $0.00 |
| Next EPS Report Date: 11/10/26 |
|
|
|
| |
